Structure and Dynamics of Macrophage Infectivity Potentiator Proteins from Pathogenic Bacteria and Protozoans Bound

Victor Hugo Pérez Carrillo1, Jacob J Whittaker2, Christoph Wiedemann1

  • 1Faculty of Chemistry and Earth Sciences, Institute of Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.

PubMed

Insights

Macrophage infectivity potentiator (MIP) proteins are crucial for pathogen virulence. This study used diverse biophysical methods to characterize novel inhibitors, revealing insights into MIP dynamics for drug development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Microbiology

Background:

  • Macrophage infectivity potentiator (MIP) proteins are virulence factors in various pathogens.
  • MIPs possess a conserved FKBP-like domain, making them targets for inhibitor design.

Purpose of the Study:

  • To determine high-resolution structures of MIP-inhibitor complexes.
  • To compare inhibitor binding dynamics across different MIPs using biophysical techniques.
  • To investigate inhibitor-induced structural changes in MIPs.

Main Methods:

  • X-ray crystallography for structural determination.
  • Nuclear Magnetic Resonance (NMR) spectroscopy (¹H, ¹⁵N, ¹⁹F) for solution-state analysis.
  • Electron Paramagnetic Resonance (EPR) spectroscopy and Small-Angle X-ray Scattering (SAXS) for probing structural dynamics.

Main Results:

  • High-resolution crystal structures of Burkholderia pseudomallei and Trypanosoma cruzi MIPs with fluorinated pipecolic acid inhibitors were obtained.
  • ¹⁹F NMR revealed distinct ligand binding dynamics across B. pseudomallei, T. cruzi, and Legionella pneumophila MIPs.
  • EPR and SAXS demonstrated inhibitor-induced global structural alterations in L. pneumophila MIP.

Conclusions:

  • Fluorinated ligands are versatile tools for characterizing inhibitor interactions with MIPs.
  • Integrating diverse biophysical methods is essential for understanding protein dynamics.
  • This research provides a basis for optimizing inhibitors targeting the conserved MIP protein family.